Venous thromboembolism in multiple myeloma is associated with increased mortality
Abstract Background In multiple myeloma, venous thromboembolism (VTE) is common, and treatments for myeloma, such as lenalidomide, increase the risk of thrombosis while improving survival. The association between VTE and survival is not well known. Objectives To determine the association between VTE...
Main Authors: | Martin W. Schoen, Kenneth R. Carson, Suhong Luo, Brian F. Gage, Ang Li, Amber Afzal, Kristen M. Sanfilippo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12411 |
Similar Items
-
Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
by: Kristen M. Sanfilippo, et al.
Published: (2022-01-01) -
Concomitant pulmonary tuberculosis and venous thromboembolism
by: K Gowrinath, et al.
Published: (2023-01-01) -
Rheumatoid arthritis and venous thromboembolic events
by: M. A. Satybaldyeva
Published: (2016-10-01) -
Nursing management of treatment-related venous thromboembolism in patients with multiple myeloma
by: Bianhong Yang, et al.
Published: (2023-04-01) -
The Risk of Venous Thromboembolism in Neuroendocrine Neoplasms
by: Monika Wójcik-Giertuga, et al.
Published: (2023-11-01)